← Back to patent-cliff list
阿普唑仑
Tier C — Watch / tradeAlprazolam
辉瑞
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：GABAAR
Brand：Tafil、Xanax/Xanax XR、Zamoprax、Xanax XR、Xanax、Panistat、Niravam
Indications (approved)：焦虑症、惊恐病
Regional status
US
批准上市
1981-10-16
EU
批准上市
China
批准上市
1988-01-01
Japan
批准上市
1984-07-01
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Alprazolam?
Approved indications include: 焦虑症, 惊恐病.
When does the Alprazolam patent expire?
No public expiry year is available for Alprazolam yet; this page updates once verified.
How do I get a quote for Alprazolam intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25